SBIR/STTR Research Award

THE MAIN OBJECTIVE OF THIS PROPOSED RESEARCH IS TO DEVELOP A MARKEDLY IMPROVED DIAGNOSTIC TEST FOR THE EARLY DETECTION OF OCCULT HEMAGLOBIN IN STOOLS OF PATIENTS.

Award identifier 9e6ce5b4162939babc26442aec64c0df12911777fc7640db7c94a9e38c48d984Awarding agency Department of Health and Human Services

Award amount

$50,000

Program and phase

SBIR · Phase I

Award year

1984

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
Immuno Modualtors Laboratories
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

THE MAIN OBJECTIVE OF THIS PROPOSED RESEARCH IS TO DEVELOP A MARKEDLY IMPROVED DIAGNOSTIC TEST FOR THE EARLY DETECTION OF OCCULT HEMAGLOBIN IN STOOLS OF PATIENTS. COLON AND RECTAL CANCER HAS SURPASSED LUNG CANCER AS THE NUMBER ONE CANCER KILLER IN THE UNITED STATES. MOST INVESTIGATORS FEEL THAT OCCULT BLEEDING IS THE MOST FREQUENT CONSEQUENCE AND MOST PREDICTIVE INDICATOR OF THE PRESENCE OF TUMOR. THE HIGH MORTALITY RATE OF NEAR 60% MAKES THE DEVELOPMENT OF A DIAGNOSTIC TEST FOR THIS CANCER OF EXTREME IMPORTANCE SINCE EARLY DETECTION IS ASSOCIATED WITH HIGH CURE RATES. A NUMBER OF TESTS HAVE BEEN DEVELOPED TO DETECT OCCULT HEMAGLOBIN IN STOOLS. THESE INCLUDE THE DILUTE TINCTURE OF GUAIAC, SATURATED GUAIAC, HEMASTAT, AND HEMOCCULT TEST. IN ADDITION, THE PUNCH-DISC RADIAL IMMUNODIFFUSION TECHNIQUE HAS BEEN DEVELOPED AND HAS DEMONSTRATED GREATER SENSITIVITY THAN THE PREVIOUSLY MENTIONED TESTS AS WELL AS A DEGREE OF SPECIFICITY NOT FOUND IN THE PREVIOUS TESTS. WE WILL DEVELOP A PUNCH-DISC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) FOR THE DETECTION OF OCCULT HEMAGLOBIN IN STOOLS. THE SENSITIVITY OF THE ASSAY SHOULD BE CLEARLY SUPERIOR TO THAT OF EXISTING TESTS. BECAUSE OF ITS GREATER SENSITIVITY, THE PUNCH-DISC ELISA WILL ALLOW DETECTION OF HEMAGLOBIN ANTIGENS AT AN EARLIER STAGE OF COLON CANCER DEVELOPMENT THAN THE PREVIOUSLY MENTIONED TESTS. AN INCREASED SURVIVOR RATE SHOULD RESULT FROM THE EARLIER DETECTION OF COLON CANCER. THIS NEWLY DEVELOPED PUNCH-DISC ELISA WILL BE EVALUATED CRITICALLY IN TERMS OF STANDARDIZATION, SENSITIVITY, SPECIFICITY, AND REPRODUCIBILITY. THESE CHARACTERISTICS ARE ESSENTIAL TO THE QUALITY CONTROL OF THE ASSAY. THE FINDINGS IN PHASE I OF THIS STUDY WILL BE USED TO PLAN THE DEMONSTRATION IN PHASE II OF THE PRACTICAL APPLICATION OF THE PUNCH-DISC ELISA AS A DIAGNOSTIC TECHNIQUE FOR THE EARLY DETECTION OF COLON CANCER AND OTHER CAUSES OF ALIMENTARY TRACT BLEEDING. THE DETECTION OF BLEEDING FROM NONCANCEROUS LESIONS COULD BE AN IMPORTANT AID IN THE CURE-RATE OF THESE LESIONS. THE PUNCH-DISC ELISA IS A SPECIFIC, SENSITIVE, ACCURATE, AND SIMPLE SCREENING PROCEDURE THAT CAN BE OF SIGNIFICANT VALUE TO PRACTIONERS, CLINICS, AND OTHER LABORATORIES AS A QUANTITATIVE ASSAY CAPABLE OF DETECTING HEMAGLOBIN ANTIGEN IN THE NANNOGRAM RANGE. AS A COLORMETRIC ASSAY, THE ELISA OFFERS THE ADVANTAGE OF BEING ADAPTABLE TO A SIMPLE AND INEXPENSIVE OFFICE AND HOME TEST.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.